Ivermectin Rx for COVID-19: Insurance coverage doesn’t match evidence
Study shows health plans paid most of the cost of ivermectin, despite the drug’s lack of official approval for use against COVID-19. Doctors continue to prescribe ivermectin – and a new study suggests health insurers are heavily subsidizing the cost of those prescriptions. The study’s authors call for insurers to align their coverage of the …